1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MOONLAKE IMMUNOTHERAPEUTICS - ORDINARY SHARES - CLASS A
MoonLake Immunotherapeutics - Ordinary Shares - Class A XNAS: MLTX
7.08 -0.09 (-1.26%)
8.8M

XNAS 01 Oct, 2025 2:24 PM (EDT)

Watchlist

Portfolio

Alert

Trial Setback
MoonLake falls on Monday as late-stage skin disease drug trial shows weaker-than-expected results See details

MoonLake Immunotherapeutics - Ordinary Shares - Class A Splits, Dividends and Corporate Actions

Check all corporate actions such as stock splits, dividends, mergers & acquisitions, and board meeting announcements for MoonLake Immunotherapeutics - Ordinary Shares - Class A